科研製薬の株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2025/06/30 | 3,830 | 3,855 | 3,817 | 3,820 | -6 | -0.2% | 118,700 |
| 2025/06/27 | 3,800 | 3,826 | 3,788 | 3,826 | +25 | +0.7% | 247,800 |
| 2025/06/26 | 3,810 | 3,846 | 3,787 | 3,801 | -9 | -0.2% | 157,300 |
| 2025/06/25 | 3,829 | 3,829 | 3,771 | 3,810 | -29 | -0.8% | 153,700 |
| 2025/06/24 | 3,845 | 3,857 | 3,811 | 3,839 | +22 | +0.6% | 140,800 |
| 2025/06/23 | 3,817 | 3,836 | 3,800 | 3,817 | -27 | -0.7% | 116,500 |
| 2025/06/20 | 3,825 | 3,857 | 3,794 | 3,844 | +19 | +0.5% | 343,600 |
| 2025/06/19 | 3,860 | 3,873 | 3,822 | 3,825 | -35 | -0.9% | 150,900 |
| 2025/06/18 | 3,845 | 3,877 | 3,845 | 3,860 | -10 | -0.3% | 106,500 |
| 2025/06/17 | 3,838 | 3,958 | 3,831 | 3,870 | +3 | +0.1% | 209,200 |
| 2025/06/16 | 3,880 | 3,892 | 3,845 | 3,867 | +12 | +0.3% | 80,600 |
| 2025/06/13 | 3,876 | 3,897 | 3,839 | 3,855 | -18 | -0.5% | 115,900 |
| 2025/06/12 | 3,842 | 3,873 | 3,834 | 3,873 | +31 | +0.8% | 173,500 |
| 2025/06/11 | 3,859 | 3,883 | 3,828 | 3,842 | -3 | -0.1% | 90,700 |
| 2025/06/10 | 3,821 | 3,860 | 3,814 | 3,845 | +25 | +0.7% | 120,200 |
| 2025/06/09 | 3,820 | 3,824 | 3,784 | 3,820 | +35 | +0.9% | 111,500 |
| 2025/06/06 | 3,786 | 3,803 | 3,754 | 3,785 | +8 | +0.2% | 142,800 |
| 2025/06/05 | 3,786 | 3,787 | 3,740 | 3,777 | -33 | -0.9% | 127,800 |
| 2025/06/04 | 3,787 | 3,826 | 3,784 | 3,810 | +28 | +0.7% | 136,600 |
| 2025/06/03 | 3,770 | 3,796 | 3,746 | 3,782 | -5 | -0.1% | 95,800 |
| 2025/06/02 | 3,830 | 3,838 | 3,771 | 3,787 | -57 | -1.5% | 168,900 |
| 2025/05/30 | 3,795 | 3,860 | 3,795 | 3,844 | +33 | +0.9% | 197,000 |
| 2025/05/29 | 3,718 | 3,862 | 3,710 | 3,811 | +88 | +2.4% | 201,700 |
| 2025/05/28 | 3,764 | 3,776 | 3,719 | 3,723 | -41 | -1.1% | 162,100 |
| 2025/05/27 | 3,764 | 3,775 | 3,753 | 3,764 | ±0 | ±0% | 122,900 |
| 2025/05/26 | 3,740 | 3,783 | 3,731 | 3,764 | +26 | +0.7% | 121,400 |
| 2025/05/23 | 3,730 | 3,751 | 3,706 | 3,738 | ±0 | ±0% | 113,000 |
| 2025/05/22 | 3,735 | 3,764 | 3,699 | 3,738 | +18 | +0.5% | 148,800 |
| 2025/05/21 | 3,735 | 3,744 | 3,700 | 3,720 | +15 | +0.4% | 196,200 |
| 2025/05/20 | 3,757 | 3,757 | 3,694 | 3,705 | -52 | -1.4% | 223,600 |
| 2025/05/19 | 3,700 | 3,757 | 3,676 | 3,757 | +32 | +0.9% | 185,600 |
| 2025/05/16 | 3,748 | 3,755 | 3,664 | 3,725 | +40 | +1.1% | 250,000 |
| 2025/05/15 | 3,741 | 3,769 | 3,651 | 3,685 | -68 | -1.8% | 222,600 |
| 2025/05/14 | 3,733 | 3,753 | 3,681 | 3,753 | -42 | -1.1% | 281,300 |
| 2025/05/13 | 3,810 | 3,834 | 3,700 | 3,795 | -72 | -1.9% | 312,600 |
| 2025/05/12 | 4,007 | 4,039 | 3,845 | 3,867 | -143 | -3.6% | 264,200 |
| 2025/05/09 | 4,037 | 4,049 | 4,010 | 4,010 | +10 | +0.3% | 191,400 |
| 2025/05/08 | 4,061 | 4,061 | 4,000 | 4,000 | -55 | -1.4% | 139,000 |
| 2025/05/07 | 4,072 | 4,075 | 3,997 | 4,055 | -17 | -0.4% | 164,000 |
| 2025/05/02 | 4,070 | 4,093 | 4,035 | 4,072 | +31 | +0.8% | 130,200 |
| 2025/05/01 | 4,065 | 4,065 | 4,016 | 4,041 | -24 | -0.6% | 114,700 |
| 2025/04/30 | 4,046 | 4,068 | 4,010 | 4,065 | +44 | +1.1% | 118,800 |
| 2025/04/28 | 4,010 | 4,068 | 4,004 | 4,021 | +7 | +0.2% | 116,400 |
| 2025/04/25 | 4,058 | 4,058 | 3,998 | 4,014 | -35 | -0.9% | 128,200 |
| 2025/04/24 | 4,125 | 4,140 | 4,031 | 4,049 | -84 | -2% | 123,600 |
| 2025/04/23 | 4,140 | 4,176 | 4,115 | 4,133 | -7 | -0.2% | 146,800 |
| 2025/04/22 | 4,105 | 4,176 | 4,105 | 4,140 | +31 | +0.8% | 125,300 |
| 2025/04/21 | 4,067 | 4,124 | 4,046 | 4,109 | +18 | +0.4% | 122,300 |
| 2025/04/18 | 4,052 | 4,100 | 4,042 | 4,091 | +71 | +1.8% | 80,900 |
| 2025/04/17 | 4,009 | 4,020 | 3,959 | 4,020 | +10 | +0.2% | 87,900 |
1～
50
件表示中 / 3731件
類似銘柄と比較する
現在ご覧いただいている「科研薬」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| 科研薬 | 377,800円 | -6.4% | -71.8% | 5.03% | 42.20倍 | 0.94倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ジーエヌアイ | 335,500円 | +21.7% | +999.9% | 0.00% | 14.05倍 | 4.65倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| サンバイオ | 233,900円 | - | - | 0.00% | - | 108.34倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 東和薬品 | 300,500円 | +7.9% | -3.3% | 2.66% | 8.36倍 | 0.86倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 205,200円 | +3.1% | -6.5% | 2.34% | 9.52倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
